{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T09:53:49Z","timestamp":1794736429117,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1I1A1A01073332"],"award-info":[{"award-number":["2022R1I1A1A01073332"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1A2C2004765"],"award-info":[{"award-number":["2019R1A2C2004765"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A2B5B02002097"],"award-info":[{"award-number":["2022R1A2B5B02002097"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Current therapies for autoimmune diseases, such as multiple sclerosis (MS), induce broad suppression of the immune system, potentially promoting opportunistic infections. Here, we report an immunosuppressive biomaterial-based therapeutic vaccine carrying self-antigen and tolerance-inducing inorganic nanoparticles to treat experimental autoimmune encephalomyelitis (EAE), a mouse model mimicking human MS. Immunization with self-antigen-loaded mesoporous nanoparticles generates Foxp3\n                    <jats:sup>+<\/jats:sup>\n                    regulatory T-cells in spleen and systemic immune tolerance in EAE mice, reducing central nervous system-infiltrating antigen-presenting cells (APCs) and autoreactive CD4\n                    <jats:sup>+<\/jats:sup>\n                    T-cells. Introducing reactive oxygen species (ROS)-scavenging cerium oxide nanoparticles (CeNP) to self-antigen-loaded nanovaccine additionally suppresses activation of APCs and enhances antigen-specific immune tolerance, inducing recovery in mice from complete paralysis at the late, chronic stage of EAE, which shows similarity to chronic human MS. This study clearly shows that the ROS-scavenging capability of catalytic inorganic nanoparticles could be utilized to enhance tolerogenic features in APCs, leading to antigen-specific immune tolerance, which could be exploited in treating MS.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-35263-9","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:10:24Z","timestamp":1669972224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Immunosuppressive biomaterial-based therapeutic vaccine to treat multiple sclerosis via re-establishing immune tolerance"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8607-569X","authenticated-orcid":false,"given":"Thanh Loc","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngjin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0847-4388","authenticated-orcid":false,"given":"Jihye","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsu","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc Man","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Woo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4687-6732","authenticated-orcid":false,"given":"Jaeyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"key":"35263_CR1","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J., Baranzini, S. E., Geurts, J., Hemmer, B. & Ciccarelli, O. Seminar multiple sclerosis. Lancet 391, 1622\u20131636 (2018).","journal-title":"Lancet"},{"key":"35263_CR2","first-page":"289","volume":"15","author":"JW Prineas","year":"2001","unstructured":"Prineas, J. W. Pathology of multiple sclerosis. Handb. Mult. Scler. Third Ed. 15, 289\u2013324 (2001).","journal-title":"Handb. Mult. Scler. Third Ed."},{"key":"35263_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/joim.12204","volume":"275","author":"F Piehl","year":"2014","unstructured":"Piehl, F. A changing treatment landscape for multiple sclerosis: challenges and opportunities. J. Intern. Med. 275, 364\u2013381 (2014).","journal-title":"J. Intern. Med."},{"key":"35263_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nri2153","volume":"7","author":"SD Miller","year":"2007","unstructured":"Miller, S. D., Turley, D. M. & Podojil, J. R. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat. Rev. Immunol. 7, 665\u2013677 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"35263_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri2138","volume":"7","author":"MG Roncarolo","year":"2007","unstructured":"Roncarolo, M. G. & Battaglia, M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 7, 585\u2013598 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"35263_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775\u2013787 (2008).","journal-title":"Cell"},{"key":"35263_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.it.2016.08.012","volume":"37","author":"M Kanamori","year":"2016","unstructured":"Kanamori, M., Nakatsukasa, H., Okada, M., Lu, Q. & Yoshimura, A. Induced regulatory T cells: their development, stability, and applications. Trends Immunol. 37, 803\u2013811 (2016).","journal-title":"Trends Immunol."},{"key":"35263_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","volume":"19","author":"M Dominguez-Villar","year":"2018","unstructured":"Dominguez-Villar, M. & Hafler, D. A. Regulatory T cells in autoimmune disease. Nat. Immunol. 19, 665\u2013673 (2018).","journal-title":"Nat. Immunol."},{"key":"35263_CR9","doi-asserted-by":"publisher","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","volume":"183","author":"A J\u00e4ger","year":"2009","unstructured":"J\u00e4ger, A., Dardalhon, V., Sobel, R. A., Bettelli, E. & Kuchroo, V. K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169\u20137177 (2009).","journal-title":"J. Immunol."},{"key":"35263_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245\u2013252 (1998).","journal-title":"Nature"},{"key":"35263_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen, L. & Flies, D. B. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 13, 227\u2013242 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"35263_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S1471-4906(01)01952-4","volume":"22","author":"H Jonuleit","year":"2001","unstructured":"Jonuleit, H., Schmitt, E., Steinbrink, K. & Enk, A. H. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22, 394\u2013400 (2001).","journal-title":"Trends Immunol."},{"key":"35263_CR13","doi-asserted-by":"publisher","first-page":"11270","DOI":"10.1073\/pnas.1120611109","volume":"109","author":"A Yeste","year":"2012","unstructured":"Yeste, A., Nadeau, M., Burns, E. J., Weiner, H. L. & Quintana, F. J. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA. 109, 11270\u201311275 (2012).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"35263_CR14","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1021\/nn405033r","volume":"8","author":"Z Hunter","year":"2014","unstructured":"Hunter, Z. et al. A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. ACS Nano 8, 2148\u20132160 (2014).","journal-title":"ACS Nano"},{"key":"35263_CR15","doi-asserted-by":"publisher","first-page":"E156","DOI":"10.1073\/pnas.1408686111","volume":"112","author":"RA Maldonado","year":"2015","unstructured":"Maldonado, R. A. et al. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance. Proc. Natl Acad. Sci. USA. 112, E156\u2013E165 (2015).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"35263_CR16","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1016\/j.celrep.2016.08.033","volume":"16","author":"LH Tostanoski","year":"2016","unstructured":"Tostanoski, L. H. et al. Reprogramming the local lymph node microenvironment promotes tolerance that is systemic and antigen specific. Cell Rep. 16, 2940\u20132952 (2016).","journal-title":"Cell Rep."},{"key":"35263_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nature16962","volume":"530","author":"X Clemente-Casares","year":"2016","unstructured":"Clemente-Casares, X. et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530, 434\u2013440 (2016).","journal-title":"Nature"},{"key":"35263_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.biomaterials.2017.07.029","volume":"143","author":"JJ Cho","year":"2017","unstructured":"Cho, J. J. et al. An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis. Biomaterials 143, 79\u201392 (2017).","journal-title":"Biomaterials"},{"key":"35263_CR19","doi-asserted-by":"crossref","unstructured":"Hess, K. L. et al. Engineering immunological tolerance using quantum dots to tune the density of self-antigen display. Adv. Funct. Mater. 27, 1700290 (2017).","DOI":"10.1002\/adfm.201700290"},{"key":"35263_CR20","doi-asserted-by":"crossref","unstructured":"Saito, E. et al. Design of biodegradable nanoparticles to modulate phenotypes of antigen-presenting cells for antigen-specific treatment of autoimmune disease. Biomaterials 222, 119432 (2019).","DOI":"10.1016\/j.biomaterials.2019.119432"},{"key":"35263_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.abc9317","volume":"6","author":"E Saito","year":"2020","unstructured":"Saito, E. et al. Modulating lung immune cells by pulmonary delivery of antigen-specific nanoparticles to treat autoimmune disease. Sci. Adv. 6, 1\u201312 (2020).","journal-title":"Sci. Adv."},{"key":"35263_CR22","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1021\/acs.nanolett.6b04130","volume":"17","author":"D Kwon","year":"2017","unstructured":"Kwon, D. et al. Extra-large pore mesoporous silica nanoparticles for directing in vivo M2 macrophage polarization by delivering IL-4. Nano Lett. 17, 2747\u20132756 (2017).","journal-title":"Nano Lett."},{"key":"35263_CR23","doi-asserted-by":"publisher","first-page":"119859","DOI":"10.1016\/j.biomaterials.2020.119859","volume":"239","author":"TL Nguyen","year":"2020","unstructured":"Nguyen, T. L., Cha, B. G., Choi, Y., Im, J. & Kim, J. Injectable dual-scale mesoporous silica cancer vaccine enabling efficient delivery of antigen\/adjuvant-loaded nanoparticles to dendritic cells recruited in local macroporous scaffold. Biomaterials 239, 119859 (2020).","journal-title":"Biomaterials"},{"key":"35263_CR24","doi-asserted-by":"crossref","unstructured":"Croissant, J. G., Fatieiev, Y. & Khashab, N. M. Degradability and clearance of silicon, organosilica, silsesquioxane, silica mixed oxide, and mesoporous silica nanoparticles. Adv. Mater. 29, 1604634 (2017).","DOI":"10.1002\/adma.201604634"},{"key":"35263_CR25","doi-asserted-by":"publisher","first-page":"13598","DOI":"10.1021\/acsami.9b19956","volume":"12","author":"E Bindini","year":"2020","unstructured":"Bindini, E. et al. Following in situ the degradation of mesoporous silica in biorelevant conditions: at last, a good comprehension of the structure influence. ACS Appl. Mater. Interfaces 12, 13598\u201313612 (2020).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"35263_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-06730-z","volume":"9","author":"P Dogra","year":"2018","unstructured":"Dogra, P. et al. Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics. Nat. Commun. 9, 1\u201314 (2018).","journal-title":"Nat. Commun."},{"key":"35263_CR27","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1021\/acsnano.7b06995","volume":"12","author":"F Campbell","year":"2018","unstructured":"Campbell, F. et al. Directing nanoparticle biodistribution through evasion and exploitation of Stab2-dependent nanoparticle uptake. ACS Nano 12, 2138\u20132150 (2018).","journal-title":"ACS Nano"},{"key":"35263_CR28","doi-asserted-by":"crossref","unstructured":"Hayashi, Y. et al. Differential nanoparticle sequestration by macrophages and scavenger endothelial cells visualized in vivo in real-time and at ultrastructural resolution. ACS Nano 14, 1665\u20131681 (2020).","DOI":"10.1021\/acsnano.9b07233"},{"key":"35263_CR29","doi-asserted-by":"publisher","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","volume":"177","author":"Y Komiyama","year":"2006","unstructured":"Komiyama, Y. et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177, 566\u2013573 (2006).","journal-title":"J. Immunol."},{"key":"35263_CR30","doi-asserted-by":"crossref","unstructured":"Kemanetzoglou, E. & Andreadou, E. CNS demyelination with TNF-\u03b1 blockers. Curr. Neurol. Neurosci. Rep. 17, 36 (2017).","DOI":"10.1007\/s11910-017-0742-1"},{"key":"35263_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.it.2015.08.004","volume":"36","author":"AL Croxford","year":"2015","unstructured":"Croxford, A. L., Spath, S. & Becher, B. GM-CSF in neuroinflammation: licensing myeloid cells for tissue damage. Trends Immunol. 36, 651\u2013662 (2015).","journal-title":"Trends Immunol."},{"key":"35263_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","volume":"32","author":"SS Iyer","year":"2012","unstructured":"Iyer, S. S. & Cheng, G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit. Rev. Immunol. 32, 23\u201363 (2012).","journal-title":"Crit. Rev. Immunol."},{"key":"35263_CR33","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.4049\/jimmunol.161.7.3767","volume":"161","author":"EH Tran","year":"1998","unstructured":"Tran, E. H., Hoekstra, K., van Rooijen, N., D, C. D. & O, T. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J. Immunol. 161, 3767\u20133775 (1998).","journal-title":"J. Immunol."},{"key":"35263_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nm1197","volume":"11","author":"M Greter","year":"2005","unstructured":"Greter, M. et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11, 328\u2013334 (2005).","journal-title":"Nat. Med."},{"key":"35263_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nri2550","volume":"9","author":"J Goverman","year":"2009","unstructured":"Goverman, J. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9, 393\u2013407 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"35263_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nm1202","volume":"11","author":"EJ McMahon","year":"2005","unstructured":"McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H. & Miller, S. D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11, 335\u2013339 (2005).","journal-title":"Nat. Med."},{"key":"35263_CR37","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","volume":"566","author":"T Masuda","year":"2019","unstructured":"Masuda, T. et al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature 566, 388\u2013392 (2019).","journal-title":"Nature"},{"key":"35263_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","volume":"251","author":"Y Gilgun-Sherki","year":"2004","unstructured":"Gilgun-Sherki, Y., Melamed, E. & Offen, D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J. Neurol. 251, 261\u2013268 (2004).","journal-title":"J. Neurol."},{"key":"35263_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","volume":"277","author":"K Ohl","year":"2016","unstructured":"Ohl, K., Tenbrock, K. & Kipp, M. Oxidative stress in multiple sclerosis: central and peripheral mode of action. Exp. Neurol. 277, 58\u201367 (2016).","journal-title":"Exp. Neurol."},{"key":"35263_CR40","doi-asserted-by":"crossref","unstructured":"Xu, C. & Qu, X. Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Mater. 6, e90 (2014).","DOI":"10.1038\/am.2013.88"},{"key":"35263_CR41","doi-asserted-by":"publisher","first-page":"9408","DOI":"10.1002\/anie.201805052","volume":"57","author":"HJ Kwon","year":"2018","unstructured":"Kwon, H. J. et al. Ceria nanoparticle systems for selective scavenging of mitochondrial, intracellular, and extracellular reactive oxygen species in Parkinson\u2019s disease. Angew. Chem. Int. Ed. 57, 9408\u20139412 (2018).","journal-title":"Angew. Chem. Int. Ed."},{"key":"35263_CR42","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1021\/acsnano.8b08785","volume":"13","author":"J Kim","year":"2019","unstructured":"Kim, J. et al. Synergistic oxygen generation and reactive oxygen species scavenging by manganese ferrite\/ceria co-decorated nanoparticles for rheumatoid arthritis treatment. ACS Nano 13, 3206\u20133217 (2019).","journal-title":"ACS Nano"},{"key":"35263_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adma.201807965","volume":"31","author":"D Kim","year":"2019","unstructured":"Kim, D., Kwon, H. J. & Hyeon, T. Magnetite\/ceria nanoparticle assemblies for extracorporeal cleansing of amyloid-\u03b2 in Alzheimer\u2019s disease. Adv. Mater. 31, 1\u20136 (2019).","journal-title":"Adv. Mater."},{"key":"35263_CR44","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1126\/science.1113955","volume":"309","author":"CT Campbell","year":"2005","unstructured":"Campbell, C. T. & Peden, C. H. F. Oxygen vacancies and catalysis on ceria surfaces. Science 309, 713\u2013714 (2005).","journal-title":"Science"},{"key":"35263_CR45","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1039\/b922024k","volume":"46","author":"T Pirmohamed","year":"2010","unstructured":"Pirmohamed, T. et al. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem. Commun. 46, 2736\u20132738 (2010).","journal-title":"Chem. Commun."},{"key":"35263_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adhm.201801548","volume":"8","author":"HG Jeong","year":"2019","unstructured":"Jeong, H. G. et al. Ceria nanoparticles fabricated with 6-aminohexanoic acid that overcome systemic inflammatory response syndrome. Adv. Healthc. Mater. 8, 1\u201310 (2019).","journal-title":"Adv. Healthc. Mater."},{"key":"35263_CR47","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/cmi.2015.44","volume":"12","author":"H Zeng","year":"2015","unstructured":"Zeng, H., Zhang, R., Jin, B. & Chen, L. Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance. Cell. Mol. Immunol. 12, 566\u2013571 (2015).","journal-title":"Cell. Mol. Immunol."},{"key":"35263_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.00532","volume":"8","author":"A Jones","year":"2017","unstructured":"Jones, A. & Hawiger, D. Peripherally induced regulatory T cells: recruited protectors of the central nervous system against autoimmune neuroinflammation. Front. Immunol. 8, 1\u20138 (2017).","journal-title":"Front. Immunol."},{"key":"35263_CR49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1365-2990.2008.00986.x","volume":"35","author":"EJ Kooi","year":"2009","unstructured":"Kooi, E. J. et al. Abundant extracellular myelin in the meninges of patients with multiple sclerosis. Neuropathol. Appl. Neurobiol. 35, 283\u2013295 (2009).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"35263_CR50","first-page":"1","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi, M. et al. Multiple sclerosis. Nat. Rev. Dis. Prim. 4, 1\u201327 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"35263_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scisignal.aad0612","volume":"9","author":"A Yeste","year":"2016","unstructured":"Yeste, A. et al. Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2. Sci. Signal. 9, 1\u201312 (2016).","journal-title":"Sci. Signal."},{"key":"35263_CR52","doi-asserted-by":"publisher","first-page":"32017","DOI":"10.1073\/pnas.2016451117","volume":"117","author":"JE Kenison","year":"2020","unstructured":"Kenison, J. E. et al. Tolerogenic nanoparticles suppress central nervous system inflammation. Proc. Natl Acad. Sci. USA. 117, 32017\u201332028 (2020).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"35263_CR53","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1016\/j.vaccine.2014.08.016","volume":"32","author":"G Cappellano","year":"2014","unstructured":"Cappellano, G. et al. Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis. Vaccine 32, 5681\u20135689 (2014).","journal-title":"Vaccine"},{"key":"35263_CR54","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1021\/acs.bioconjchem.7b00624","volume":"29","author":"LM Casey","year":"2018","unstructured":"Casey, L. M. et al. Conjugation of transforming growth factor beta to antigen-loaded poly(lactide-co-glycolide) nanoparticles enhances efficiency of antigen-specific tolerance. Bioconjug. Chem. 29, 813\u2013823 (2018).","journal-title":"Bioconjug. Chem."},{"key":"35263_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.586220","volume":"12","author":"BE Phillips","year":"2021","unstructured":"Phillips, B. E. et al. Arrest in the progression of type 1 diabetes at the mid-stage of insulitic autoimmunity using an autoantigen-decorated all-trans retinoic acid and transforming growth factor beta-1 single microparticle formulation. Front. Immunol. 12, 1\u201315 (2021).","journal-title":"Front. Immunol."},{"key":"35263_CR56","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.2147\/IJN.S164500","volume":"13","author":"W Pei","year":"2018","unstructured":"Pei, W. et al. Direct modulation of myelin-autoreactive CD4+ and CD8+ T cells in EAE mice by a tolerogenic nanoparticle co-carrying myelin peptide-loaded major histocompatibility complexes, CD47 and multiple regulatory molecules. Int. J. Nanomed. 13, 3731\u20133750 (2018).","journal-title":"Int. J. Nanomed."},{"key":"35263_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aaw9668","volume":"13","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Modular immune-homeostatic microparticles promote immune tolerance in mouse autoimmune models. Sci. Transl. Med. 13, 1\u201314 (2021).","journal-title":"Sci. Transl. Med."},{"key":"35263_CR58","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.molimm.2013.08.006","volume":"57","author":"B Yuan","year":"2014","unstructured":"Yuan, B. et al. A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis. Mol. Immunol. 57, 93\u201399 (2014).","journal-title":"Mol. Immunol."},{"key":"35263_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4110\/in.2019.19.e19","volume":"19","author":"HH Jung","year":"2019","unstructured":"Jung, H. H. et al. Polymeric nanoparticles containing both antigen and vitamin d3 induce antigen-specific immune suppression. Immune Netw. 19, 1\u201312 (2019).","journal-title":"Immune Netw."},{"key":"35263_CR60","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1021\/acsanm.1c03726","volume":"5","author":"TL Nguyen","year":"2022","unstructured":"Nguyen, T. L. & Kim, J. Nanoparticle-based tolerogenic vaccines for the treatment of autoimmune diseases: a review. ACS Appl. Nano Mater. 5, 6013\u20136028 (2022).","journal-title":"ACS Appl. Nano Mater."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35263-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35263-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35263-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T05:46:12Z","timestamp":1678859172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35263-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["35263"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-35263-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,2]]},"assertion":[{"value":"18 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.L.N. and J.K. have a patent application for formulating a multiple sclerosis vaccine (Republic of Korea, Application No. 10-2022-0009549). The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7449"}}